COSTS OF ACUTE HEART FAILURE IN SOUTH KOREA

Author(s)

Kwon H1, Kim J2, Kim E2, Yu E2, Yang B2, Yoon S3, Lee J3, Kim S3
1Institute of Health and Environment, seoul, South Korea, 2Seoul National University, Seoul, South Korea, 3Novartis Korea.Ltd., seoul, South Korea

OBJECTIVES: The purpose of this study was to find the total medical expenditure and utilization of trends in medical resource for patients hospitalized and diagnosed with heart failure. METHODS: : Heart failure patients were identified from the Korean HIRA_NIS Data (National Health Insurance Claims’ Sample data) of 2011, provided by Health Insurance Review & Assessment Service (HIRA) in South Korea. Heart failure inpatient was defined as the one whose primary diagnosis ICD-10 code is I50. The analysis of relations between total medical expenditure and possible variables are processed through regression analysis. RESULTS: The average medical cost per inpatient with heart failure was KRW 3,167,969 (USD 2,970.16). The medical cost per inpatient showed KRW 3,627,711 (USD 3,401.19) KRW 2,500,556 (USD 2,344.42) KRW 1,668,074 (USD 1,563.92) in the university hospitals, general hospitals, and secondary hospitals, respectively. The  number of visit to hospital for each patient was 1.7 times per year. The average hospital stay for inpatient was 24.6 days. The essential hypertension, arterial fibrillation and flutter, and angina pectoris were ranked to be the most prevalent secondary disease for heart failure in-patients. According to the result of multivariate regression analysis, with observation of 8,557 heart failure inpatients, factors including the age of 40 and over, male, visit days and renal impairment showed a significant increase in  total medical expenditure.  Especially, renal impairment  was the largest impact on the increase in treatment cost of heart failure (coefficient=2,831,614 SD 123,951, p<0.001). CONCLUSIONS: Although extra billing cost could not be identified with NHI claims data, this analysis suggests that heart failure is a considerable disease with great medical expenditure. In consideration of total medical expenditure, it can be expected that patients, hospitals, and national health care department are currently in severe economic burden.

Conference/Value in Health Info

2014-05, ISPOR 2014, Palais des Congres de Montreal

Value in Health, Vol. 17, No. 3 (May 2014)

Code

PCV60

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×